About this trial
* Binge Eating Disorder (BED) has been fairly recently introduced into the Diagnostic and Statistical Manual 5 psychiatric classification and its severity criteria are still not well established. * Moreover, it remains unclear whether BED is associated with greater metabolic severity or more somatic comorbidities, especially in obesity. * Improved BED severity staging could lead to a better definition of management strategies and , therefore, facilitate screening and care.
The investigators' hypothesis is that an improved assessment of the impulsivity-compulsivity spectrum, emotional regulation, attentional impairment and somatic or psychiatric comorbidities will result in a better distinction between the severe form of BED (e.g., highly impulsive and somatically complicated) from milder form (e.g., more compulsive and less somatically complicated).
Eligibility criteria
Qualifiers
men or women aged 1
participants eligible for bariatric surgery (BMI>40, or BMI>35 with severe comorbidities)
participants scheduled for medical evaluation and treatment of obesity at the IUCPQ Obesity Clinic (BMI≥30)
participants scheduled for evaluation and treatment of BED at the CEPIA with obesity (BMI≥30)
Disqualifiers
participants with severe neurological disorder and/or major neurocognitive deficits;
participants with previous bariatric surgery or with introduction or change of anti-obesity medication (liraglutide or naltrexone/bupropion) in the previous 3 months;
participants who cannot read and/or understand French;
participants under guardianship or curatorship;
Trial design
Treatments tested in this trial
- Observational
Treatment groups
Sponsors and collaborators
Laval University
Lead sponsor
Institut universitaire de cardiologie et de pneumologie de Québec, University Laval
Collaborator
Centre d'expertise Poids, Image et Alimentation (CEPIA)
Collaborator